Management of hepatitis B virus (HBV) infection in immunosuppressed oncohematologic patients (OHPs): lamivudine (Lam) prophylaxis and rescue therapy of HBV infection reactivation

被引：0
|
作者：
Marrone, Aldo [1 ]
Esposito, Mariarosaria [2 ]
D'Amore, Chiara [1 ]
Siniscalchi, Isabella [1 ]
Salpini, Romina [3 ]
Ciotti, Marco [3 ]
Clccozzi, Massimo [4 ]
Perno, Carlo Federico [3 ]
Mastrullo, Lucia [2 ]
机构：
[1] Univ Naples 2, Naples, Italy
[2] San Gennaro Hosp, Hematol Unit, Naples, Italy
[3] Univ Rome, Dept Expt Med & Biochem Sci, Rome, Italy
[4] Natl Inst Hlth Italy, Dept Infect Parasit & Immune Mediated Dis, Epidemiol Sect, Rome, Italy
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
997
引用
收藏
页码：688A / 688A
页数：1
相关论文
共 50 条
  • [1] MANAGEMENT OF HBV INFECTION IN ONCOHEMATOLOGIC IMMUNOSUPPRESSED PATIENTS: LAMIVUDINE PROPHYLAXIS AND RESCUE THERAPY OF OCCULT HBV INFECTION REACTIVATION.
    Marron, A.
    Esposito, M.
    D'Amore, C.
    Siniscalchi, L.
    Rinaldi, L.
    Mastrullo, L.
    HAEMATOLOGICA, 2013, 98 : 182 - 182
  • [2] Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: The German guidelines for the management of HBV infection
    Cornberg, M.
    Protzer, U.
    Dollinger, M. M.
    Petersen, J.
    Wedemeyer, H.
    Berg, T.
    Jilg, W.
    Erhardt, A.
    Wirth, S.
    Schirmacher, P.
    Fleig, W. E.
    Manns, M. P.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (12): : 1281 - 1328
  • [3] Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation
    Pawlowska, Malgorzata
    Flisiak, Robert
    Gil, Lidia
    Horban, Andrzej
    Hus, Iwona
    Jaroszewicz, Jerzy
    Lech-Maranda, Ewa
    Styczynski, Jan
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 5 (03) : 195 - 202
  • [4] Spontaneous Reactivation of Hepatitis B Virus (HBV) Infection in Patients With Resolved or Occult HBV Infection
    Kamitsukasa, Hiroshi
    Iri, Masanobu
    Tanaka, Akihisa
    Nagashima, Shigeo
    Takahashi, Masaharu
    Nishizawa, Tsutomu
    Okamoto, Hiroaki
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (04) : 589 - 600
  • [5] Management and outcome of lamivudine(LAM)-resistant hepatitis B virus (HBV) infection after liver transplantation (LT).
    Shields, PL
    Ling, R
    Harrison, T
    Boxall, E
    Elias, E
    Mutimer, DJ
    HEPATOLOGY, 1997, 26 (04) : 527 - 527
  • [6] Monitoring patients with a resolved hepatitis B virus infection for HBV reactivation
    Tamori, A.
    Kozuka, R.
    Motoyama, H.
    Fujii, H.
    Hagihara, A.
    Uchida-Kobayashi, S.
    Morikawa, H.
    Enomoto, M.
    Murakami, Y.
    Kawada, N.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S478 - S478
  • [7] Combination prophylaxis with lamivudine (LAM) and hepatitis B immunoglobulin (HBIG) prevents graft re-infection by hepatitis B (HBV)
    Lai, V
    Elias, E
    O'Donnell, K
    Mutimer, D
    GUT, 2002, 50 : A115 - A115
  • [8] Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection
    Kanaan, N
    Horsmans, Y
    Goffin, E
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 208 - 210
  • [9] The efficacy of lamivudine in hemodialysis patients with chronic hepatitis B virus (HBV) infection.
    Besisik, FS
    Dincer, D
    Turkoglu, S
    Cakaloglu, Y
    Sever, MS
    Okten, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1080 - A1080
  • [10] Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
    van Boemmel, Florian
    Zoellner, Bernhard
    Sarrazin, Christoph
    Spengler, Ulrich
    Hueppe, Dietrich
    Moeller, Bernd
    Feucht, Heinz-Hubert
    Wiedenmann, Bertram
    Berg, Thomas
    HEPATOLOGY, 2006, 44 (02) : 318 - 325
12345